Third Harmonic Bio Statistics
Total Valuation
THRD has a market cap or net worth of $156.29 million. The enterprise value is -$123.54 million.
Important Dates
The last earnings date was Thursday, March 27, 2025, before market open.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
THRD has 45.10 million shares outstanding. The number of shares has increased by 5.26% in one year.
| Current Share Class | 45.10M |
| Shares Outstanding | 45.10M |
| Shares Change (YoY) | +5.26% |
| Shares Change (QoQ) | +8.50% |
| Owned by Insiders (%) | 3.18% |
| Owned by Institutions (%) | 39.04% |
| Float | 13.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 40.87, with a Debt / Equity ratio of 0.01.
| Current Ratio | 40.87 |
| Quick Ratio | 40.10 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -16.41% and return on invested capital (ROIC) is -13.11%.
| Return on Equity (ROE) | -16.41% |
| Return on Assets (ROA) | -12.86% |
| Return on Invested Capital (ROIC) | -13.11% |
| Return on Capital Employed (ROCE) | -20.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.52M |
| Employee Count | 30 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.94% in the last 52 weeks. The beta is 2.87, so THRD's price volatility has been higher than the market average.
| Beta (5Y) | 2.87 |
| 52-Week Price Change | -62.94% |
| 50-Day Moving Average | 4.11 |
| 200-Day Moving Average | 10.23 |
| Relative Strength Index (RSI) | 37.31 |
| Average Volume (20 Days) | 341,820 |
Short Selling Information
The latest short interest is 1.54 million, so 3.40% of the outstanding shares have been sold short.
| Short Interest | 1.54M |
| Short Previous Month | 1.62M |
| Short % of Shares Out | 3.40% |
| Short % of Float | 11.79% |
| Short Ratio (days to cover) | 3.92 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -58.87M |
| Pretax Income | -32.74M |
| Net Income | -45.47M |
| EBITDA | -58.82M |
| EBIT | -58.87M |
| Earnings Per Share (EPS) | -$1.09 |
Full Income StatementBalance Sheet
The company has $285.06 million in cash and $3.21 million in debt, giving a net cash position of $281.86 million or $6.25 per share.
| Cash & Cash Equivalents | 285.06M |
| Total Debt | 3.21M |
| Net Cash | 281.86M |
| Net Cash Per Share | $6.25 |
| Equity (Book Value) | 285.15M |
| Book Value Per Share | 6.36 |
| Working Capital | 283.43M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.50 million and capital expenditures -$10,000, giving a free cash flow of -$34.51 million.
| Operating Cash Flow | -34.50M |
| Capital Expenditures | -10,000 |
| Free Cash Flow | -34.51M |
| FCF Per Share | -$0.77 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |